New drug aims to melt artery plaque in High-Risk patients
Disease control
ENROLLING_BY_INVITATION
This study tests an experimental drug, DR10624, to see if it can reduce fatty buildup (plaque) in the neck arteries of people with very high triglycerides. About 40 adults aged 18-65 will receive weekly injections of either the drug or a placebo for 24 weeks. The main goal is to …
Phase: NA • Sponsor: Junbo Ge • Aim: Disease control
Last updated May 13, 2026 16:03 UTC